Hospice News February 11, 2025
A U.S. Justice Department (DOJ) victory in its lawsuit to block UnitedHealth Group’s (NYSE: UNH) acquisition of Amedisys (Nasdaq: AMED) is unlikely to have a cooling effect on hospice M&A, according to some experts.
The UnitedHealth Group subsidiary Optum in June 2023 agreed to acquire Amedisys in a $3.3 billion deal. Optum in February 2023 also acquired the home health and hospice provider LHC Group for $5.4 billion. DOJ in December 2024 filed the lawsuit to kill the deal. The state attorneys general of Maryland, Illinois, New Jersey, and New York are also plaintiffs in the suit.
But even if DOJ succeeds in blocking the deal, an M&A turndown is unlikely, according to Tyler Giesting, director of the transaction consulting...
Today's Sponsors
Today's Sponsor